Pelvic Congestion Syndrome and Endometriosis

NCT ID: NCT03568149

Last Updated: 2019-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-14

Study Completion Date

2019-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The pelvic congestion syndrome (PCS) is a complex and multifactorial condition associated with inflammatory and hormonal etiophatogenesis similar to the endometriosis.

Furthermore, both pathologies share same clinical symptoms as chronic pelvic pain and dyspareunia.

Our hypothesis is that PCS prevalence is higher in patients with endometriosis than in those without clinical or ultrasound signs of endometriosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients undergoing routine gynecological examinations are included in the study.

Patients are divided into 2 groups:

* Group A: with endometriosis
* Group B: without clinical or ultrasound signs of endometriosis This is an observational, monocentric, prospective, exploratory study. The aim is to assess PCS incidence, associated symptoms and ultrasound characteristics in patients with endometriosis and to compare those findings to those of patients who do not present clinical or ultrasound signs of endometriosis.

The study also evaluates the correlation between:

* Type of pain symptoms (dysmenorrhea, chronic pelvic pain, ovulation pain, dyspareunia, dysuria, dyschezia) and PCS
* Pain severity (assessed according to VAS scale from 0= no pain to 10= unbearable pain) and PCS
* Symptoms and ongoing medical treatments
* History of pelvic surgery and PCS.

Ultrasound parameters of pelvic vascular insufficiency are:

* Ovarian vein diameter \<4mm
* Slow ovarian blood flow (\<3cm/sec)
* Retrograde blood flow
* Dilated arcuate veins communicating with pelvic varices
* The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

* Standard 2D study: it allows to measure vessels diameter
* Vascular doppler study: it allows to evaluate flow direction and blood speed
* 3D color study: it allows a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.
* Ultrasound images are evaluated independently by two operators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Congestive Syndrome Endometriosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A: endometriosis

assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.

assessment of pain symptoms at first medical examination

Intervention Type PROCEDURE

First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.

assessment of pelvic vascular insufficiency signs

Intervention Type PROCEDURE

Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:

* Ovarian vein diameter \<4mm
* Slow ovarian blood flow (\<3cm/sec)
* Retrograde blood flow
* Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

* Standard 2D study, to measure vessels diameter
* Vascular doppler study, to evaluate flow direction and blood speed
* 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.

Group B: no endometriosis

assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.

assessment of pain symptoms at first medical examination

Intervention Type PROCEDURE

First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.

assessment of pelvic vascular insufficiency signs

Intervention Type PROCEDURE

Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:

* Ovarian vein diameter \<4mm
* Slow ovarian blood flow (\<3cm/sec)
* Retrograde blood flow
* Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

* Standard 2D study, to measure vessels diameter
* Vascular doppler study, to evaluate flow direction and blood speed
* 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

assessment of pain symptoms at first medical examination

First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.

Intervention Type PROCEDURE

assessment of pelvic vascular insufficiency signs

Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:

* Ovarian vein diameter \<4mm
* Slow ovarian blood flow (\<3cm/sec)
* Retrograde blood flow
* Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

* Standard 2D study, to measure vessels diameter
* Vascular doppler study, to evaluate flow direction and blood speed
* 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Obtaining Informed Consent
* Nulliparity
* Clinical or ultrasounds signs of endometriosis


* Obtaining Informed Consent
* Nulliparity

Exclusion Criteria

* Menopause
* Actual or previous pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Mabrouk

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital

Bologna, BO, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Diego Raimondo

Role: CONTACT

00390512144385

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Diego Raimondo

Role: primary

00390512144385

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VES Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endometriosis Pain
NCT06101303 RECRUITING
Endometriosis and Pain
NCT03993197 COMPLETED NA